42288-20-0 Usage
Uses
Used in Pharmaceutical Industry:
3-Bromophenylglycine is used as an intermediate in the production of various drugs, including anti-inflammatory agents and antibiotics. Its versatile chemical structure facilitates the synthesis of complex molecules, contributing to the development of novel therapeutic agents.
Used in Medicinal Research:
3-Bromophenylglycine is used as a valuable tool in medicinal research due to its range of biological activities. It aids in the discovery and development of new drugs by providing a foundation for the creation of more complex and effective pharmaceutical compounds.
Used in Agrochemical Industry:
Although not explicitly mentioned in the provided materials, given its role as a building block in the synthesis of agrochemicals, 3-bromophenylglycine can be inferred to be used as an intermediate in the development of pesticides, herbicides, and other agricultural chemicals to improve crop yields and protect plants from pests and diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 42288-20-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,2,2,8 and 8 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 42288-20:
(7*4)+(6*2)+(5*2)+(4*8)+(3*8)+(2*2)+(1*0)=110
110 % 10 = 0
So 42288-20-0 is a valid CAS Registry Number.
42288-20-0Relevant academic research and scientific papers
Mechanosynthesis of sydnone-containing coordination complexes
Pétry, Nicolas,Vanderbeeken, Thibaut,Malher, Astrid,Bringer, Yoan,Retailleau, Pascal,Bantreil, Xavier,Lamaty, Frédéric
supporting information, p. 9495 - 9498 (2019/08/15)
N-Phenyl-4-(2-pyridinyl) sydnone was shown to act as a four-electron donor N,O-ligand in unprecedented coordination complexes featuring three different metallic centers (Co, Cu, and Zn). Starting with various anilines, the use of a ball-mill efficiently enabled the synthesis of N-arylglycines, subsequent nitrosylation and cyclization into sydnones, and further metalation.
Pharmaceutical compositions containing a 4, 5-dihydro-1, 3-thiazol-2-ylamine derivative, novel derivatives and preparation thereof
-
, (2011/05/18)
The present invention relates to pharmaceutical compositions containing, as active principle, a 4,5-dihydro-1,3-thiazol-2-ylamine derivative of formula (I): in which R represents an —alk—S—alk—Ar radical, a phenyl radical or a phenyl radical substituted w
